EUS-guided radiofrequency ablation for pancreatic lesions
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests how safe and effective endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is for treating pancreatic growths that might become cancer or already are cancer. It is for people who are already scheduled to have this procedure as part of their care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a pancreatic lesion that could turn into cancer or is already cancerous
- You are already planning to have a procedure called EUS-RFA to treat this lesion
- You do not have another type of cancer (now or in the past)
- You are able to understand the study and give your consent to take part
- You can make it to all the follow-up appointments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial is testing a new endoscopic (from inside the stomach) approach for pancreatic ductal adenocarcinoma that is locally advanced and cannot be removed with surgery. It may help some people who have already tried first chemotherapy and still have a tumor confined to the pancreas area (no spread).
This trial uses a special endoscope (EUS) to take samples of your pancreatic tumor and then analyzes those samples with advanced tests to see if we can predict whether the cancer will come back or spread. It may help tailor your treatment plan.
This trial tests a combination of endoscopic ultrasound-guided heat ablation (RFA) and the immunotherapy drug pembrolizumab for people with locally advanced or metastatic pancreatic cancer that cannot be surgically removed. The goal is to see if this approach can shrink tumors and improve outcomes.
This Phase 2 trial is for people with pancreatic ductal adenocarcinoma (a type of pancreatic cancer) confirmed by biopsy. It tests a new treatment strategy after the cancer is diagnosed and considers people who haven’t had certain chemotherapy yet.
This trial studies an endoscopy-guided procedure that aims to treat certain pancreatic tumors using a targeted heat “burn.” It may help people who have a pancreatic tumor but cannot safely have surgery, or who prefer a non-surgical approach.
This trial tests a minimally invasive endoscopic procedure that uses heat to treat certain pancreatic cysts (fluid-filled sacs) and small neuroendocrine tumors (hormone-producing growths). It may be an option if surgery isn't possible or if you prefer to avoid it.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.